Cannabidiol in the context of sleeping disorders-induced oxidative stress

1. Weber F, Dan Y. Circuit-based interrogation of sleep control. Nature. 2016, 538 (7623): 51-59.10.1038/nature1977327708309 Search in Google Scholar

2. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010, 11 (8): 589-99.10.1038/nrn286820631712 Search in Google Scholar

3. Datta S. Cellular and chemical neuroscience of mammalian sleep. Sleep Med. 2010, 11 (5): 431-40.10.1016/j.sleep.2010.02.002285486320359944 Search in Google Scholar

4. Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev. 2006, 10 (1): 49-62.10.1016/j.smrv.2005.05.00216376591 Search in Google Scholar

5. Amici R, Bastianini S, Berteotti C et al. Sleep and bodily functions: the physiological interplay between body homeostasis and sleep homeostasis. Arch Ital Biol. 2014, 152 (2-3): 66-78. Search in Google Scholar

6. Besedovsky L, Lange T, Haack M. The Sleep-Immune Crosstalk in Health and Disease. Physiol Rev. 2019, 99 (3): 1325-1380.10.1152/physrev.00010.2018668974130920354 Search in Google Scholar

7. Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007, 11 (3): 163-78.10.1016/j.smrv.2007.01.002199133717442599 Search in Google Scholar

8. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011, 32 (12): 1484-92.10.1093/eurheartj/ehr00721300732 Search in Google Scholar

9. Dettoni JL, Consolim-Colombo FM, Drager LF et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985). 2012, 113 (2): 232-6.10.1152/japplphysiol.01604.201122539169 Search in Google Scholar

10. Pace-Schott EF, Germain A, Milad MR. Effects of sleep on memory for conditioned fear and fear extinction. Psychol Bull. 2015, 141 (4): 835-57.10.1037/bul0000014448661025894546 Search in Google Scholar

11. Jîtcă G, Ősz BE, Tero-Vescan A, Vari CE. Psychoactive Drugs-From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission. A Review. Antioxidants. 2021, 10 (3): 381.10.3390/antiox10030381800078233806320 Search in Google Scholar

12. Jîtcă G, Ősz BE, Tero-Vescan A et al. Positive Aspects of Oxidative Stress at Different Levels of the Human Body: A Review. Antioxidants. 2022, 11 (3): 572.10.3390/antiox11030572894483435326222 Search in Google Scholar

13. Rahal A, Kumar A, Singh V et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014: 761264.10.1155/2014/761264392090924587990 Search in Google Scholar

14. Atrooz F, Liu H, Kochi C, Salim S. Early Life Sleep Deprivation: Role of Oxido-Inflammatory Processes. Neuroscience. 2019, 406: 22-37.10.1016/j.neuroscience.2019.02.021651147330826520 Search in Google Scholar

15. Stefanescu C, Ciobica A. The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disord. 2012, 143 (1-3): 34-8.10.1016/j.jad.2012.05.02222840610 Search in Google Scholar

16. Guney E, Fatih Ceylan M, Tektas A et al. Oxidative stress in children and adolescents with anxiety disorders. J Affect Disord. 2014, 156: 62-6.10.1016/j.jad.2013.11.01624326157 Search in Google Scholar

17. Reimund, Eric. The free radical flux theory of sleep. Medical hypotheses, 1994, 43 (4): 231-3.10.1016/0306-9877(94)90071-X Search in Google Scholar

18. Ramanathan L, Gulyani S, Nienhuis R, Siegel JM. Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport. 2002, 13 (11): 1387-90.10.1097/00001756-200208070-00007880288512167758 Search in Google Scholar

19. Everson CA, Laatsch CD, Hogg N. Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol. 2005, 288 (2): R374-83.10.1152/ajpregu.00565.200415472007 Search in Google Scholar

20. Ramanathan L, Hu S, Frautschy SA, Siegel JM. Short-term total sleep deprivation in the rat increases antioxidant responses in multiple brain regions without impairing spontaneous alternation behavior. Behav Brain Res. 2010, 207 (2): 305-9.10.1016/j.bbr.2009.10.014281506919850085 Search in Google Scholar

21. Solanki N, Atrooz F, Asghar S, Salim S. Tempol protects sleep-deprivation induced behavioral deficits in aggressive male Long-Evans Search in Google Scholar

22. Irwin MR, Wang M, Ribeiro D et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008, 64 (6): 538-40.10.1016/j.biopsych.2008.05.004254740618561896 Search in Google Scholar

23. Irwin MR, Witarama T, Caudill M, Olmstead R, Breen EC. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun. 2015, 47: 86-92.10.1016/j.bbi.2014.09.017440162025451613 Search in Google Scholar

24. van Leeuwen WM, Lehto M, Karisola P et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One. 2009, 4 (2): e4589.10.1371/journal.pone.0004589264300219240794 Search in Google Scholar

25. Wright KP Jr, Drake AL, Frey DJ, Fleshner M, Desouza CA, Gronfier C, Czeisler CA. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav Immun. 2015, 47: 24-34.10.1016/j.bbi.2015.01.004540176625640603 Search in Google Scholar

26. Chennaoui M, Gomez-Merino D, Drogou C et al. Effects of exercise on brain and peripheral inflammatory biomarkers induced by total sleep deprivation in rats. J Inflamm (Lond). 2015, 12: 56.10.1186/s12950-015-0102-3458868526425116 Search in Google Scholar

27. Nahirnyj A, Livne-Bar I, Guo X, Sivak JM. ROS detoxification and proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature astrocyte activation. PLoS One. 2013, 8 (12): e83049.10.1371/journal.pone.0083049387164724376630 Search in Google Scholar

28. Kraus SS, Rabin LA. Sleep America: managing the crisis of adult chronic insomnia and associated conditions. J Affect Disord. 2012, 138 (3): 192-212.10.1016/j.jad.2011.05.01421652083 Search in Google Scholar

29. ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod. 2017, 103: 1-36.10.1007/978-3-319-45541-9_128120229 Search in Google Scholar

30. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008, 153 (2): 199-215.10.1038/sj.bjp.0707442221953217828291 Search in Google Scholar

31. Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB. Allosteric and orthosteric pharmacology of cannabidiol and cannabidi- ol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br J Pharmacol. 2019, 176: 1455–1146.10.1111/bph.14440648755629981240 Search in Google Scholar

32. Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010, 160 (3): 530-43.10.1111/j.1476-5381.2010.00790.x293155420590563 Search in Google Scholar

33. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018, 49: 12-19.10.1016/j.ejim.2018.01.00429307505 Search in Google Scholar

34. Tura M, Mandrioli M, Gallina Toschi T. Preliminary study: comparison of anti- oxidant activity of cannabidiol (CBD) and α-tocopherol added to refined olive and sunflower oils. Molecules. 2019, 24: 1–15.10.3390/molecules24193485680425431561446 Search in Google Scholar

35. De Briyne N, Holmes D, Sandler I et al. Cannabis, Cannabidiol Oils and Tetrahydrocannabinol-What Do Veterinarians Need to Know? Animals. 2021, 11 (3): 892.10.3390/ani11030892800388233804793 Search in Google Scholar

36. Romanian Parliament, Law No nr.339/2005 on the legal regime for narcotic and psychotropic plants, substances and preparations, Romanian Official Gazette, nr. 1095/05.12.2005. Search in Google Scholar

37. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology. 2004, 24 (3): 305-313.10.1097/01.jcp.0000125688.05091.8f15118485 Search in Google Scholar

38. Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981, 21 (S1): 417S-427S.10.1002/j.1552-4604.1981.tb02622.x7028792 Search in Google Scholar

39. Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Braz J Psychiatry. 2008, 30 (3): 271-80.10.1590/S1516-4446200800030001518833429 Search in Google Scholar

40. Chagas MH, Crippa JA, Zuardi AW et al. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. J Psychopharmacol. 2013, 27 (3): 312-6.10.1177/026988111247452423343597 Search in Google Scholar

41. Hsiao YT, Yi PL, Li CL, Chang FC. Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. Neuropharmacology. 2012, 62 (1): 373-84.10.1016/j.neuropharm.2011.08.01321867717 Search in Google Scholar

42. Shannon S, Opila-Lehman J. Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report. Integr Med (Encinitas). 2015, 14 (6): 31-5. Search in Google Scholar

43. Cooray R, Gupta V, Suphioglu C. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review. Mol Neurobiol. 2020, 57 (11): 4878-4890.10.1007/s12035-020-02054-6751585432813239 Search in Google Scholar

44. Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson’s disease. Lancet Neurol. 2021, 20 (7): 559-572.10.1016/S1474-4422(21)00061-234146514 Search in Google Scholar

45. Chagas MH, Eckeli AL, Zuardi AW et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. J Clin Pharm Ther. 2014, 39 (5): 564-6.10.1111/jcpt.1217924845114 Search in Google Scholar

46. Raskind MA, Peterson K, Williams T et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013, 170 (9): 1003-10.10.1176/appi.ajp.2013.1208113323846759 Search in Google Scholar

47. Fogaça MV, Reis FM, Campos AC, Guimarães FS. Effects of intraprelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Eur Neuropsychopharmacol. 2014, 24 (3): 410-9.10.1016/j.euroneuro.2013.10.01224321837 Search in Google Scholar

48. Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015, 16 (12): 705-18.10.1038/nrn4036587191326585799 Search in Google Scholar

49. Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009, 15 (1): 84-8.10.1111/j.1755-5949.2008.00071.x649401119228182 Search in Google Scholar

50. Ferguson, G and Ware Ma. Review Article: Sleep, Pain and Cannabis. Journal of sleep disorders and therapy. 2015, 4: 1-5. Search in Google Scholar

51. Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010 Feb 1;110(2):604-10.10.1213/ANE.0b013e3181c76f7020007734 Search in Google Scholar